Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

The role of NRF-2 and p38 MAPK on the function of human parenchymal fibroblasts

Anna Lagan, Nicola Green, Andrew Walker, Gisli Jenkins, Simon Johnson, Andrew Fisher, Alan Knox
European Respiratory Journal 2013 42: P4730; DOI:
Anna Lagan
1Division of Respiratory Medicine and Nottingham Respiratory Research Unit, University of Nottingham, Nottingham, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicola Green
2Fibrosis and Repair Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Walker
2Fibrosis and Repair Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gisli Jenkins
1Division of Respiratory Medicine and Nottingham Respiratory Research Unit, University of Nottingham, Nottingham, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon Johnson
3Division of Therapeutics and Molecular Medicine, University of Nottingham, Nottingham, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Fisher
2Fibrosis and Repair Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan Knox
1Division of Respiratory Medicine and Nottingham Respiratory Research Unit, University of Nottingham, Nottingham, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Oxidative stress and chronic inflammation are key processes in COPD. Damage to the alveolar epithelium signals to fibroblasts to implement the repair process. Dysregulation in this process can lead to alveolar destruction as seen in emphysema. Sulforaphane (SFN) activates NRF-2 and upregulates antioxidant genes. VX745 inhibits p38MAPK and plays a role in cytokine production. Both are targets for the treatment of COPD. We hypothesised that the compounds would modify the response of parenchymal fibroblasts suffering exogenous stress.

Fibroblasts were grown from parenchymal explants. Confluent cells were serum starved for 24h, pre-treated with SFN & VX745 and stimulated with Cytomix (TNFα IFNγ IL-1β) +/- H2O2, IL-1 β, TNFα or TGFβ. IL-6 and IFNγ were detected in supernatant by ELISA. Collagen 1 & 3, Integrin β5 and β8 expression was quantitated by qPCR. Proliferation and apoptosis was assessed by BrdU incorporation and CaspACE3 assay. Cytomix+/- H2O2 induced IL-6 and IFNγ release into the supernatant. VX745 and SFN had no effect. IL-1β, TNFα and TGFβ induced IL-6. VX745 had a small inhibitory effect on all agonists but SFN was ineffective. Cytomix+/- H2O2 decreased collagen 1, 3 and Integrin β5 and β8 mRNA expression which was decreased further by SFN whereas VX745 exerted no effect. SFN inhibited proliferation and caused minor dose-dependent increase in apoptosis. VX745 limited proliferation and increased apoptosis at high doses.

There was no difference in responses to p38 inhibition or NRF-2 activation from normal fibroblasts and fibroblasts from patients with COPD. Neither the p38 nor the NRF-2 pathways are likely to be targets for modifying fibroblast function in COPD. On behalf of COPDMAP consortium.

  • COPD - mechanism
  • Inflammation
  • Cell biology
  • © 2013 ERS
Previous
Back to top
Vol 42 Issue Suppl 57 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The role of NRF-2 and p38 MAPK on the function of human parenchymal fibroblasts
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The role of NRF-2 and p38 MAPK on the function of human parenchymal fibroblasts
Anna Lagan, Nicola Green, Andrew Walker, Gisli Jenkins, Simon Johnson, Andrew Fisher, Alan Knox
European Respiratory Journal Sep 2013, 42 (Suppl 57) P4730;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
The role of NRF-2 and p38 MAPK on the function of human parenchymal fibroblasts
Anna Lagan, Nicola Green, Andrew Walker, Gisli Jenkins, Simon Johnson, Andrew Fisher, Alan Knox
European Respiratory Journal Sep 2013, 42 (Suppl 57) P4730;
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Inhibition of asthma-related immunological responses in mast cells and Th2 cell lines by cultured epithelial cell lines
  • Altered scavenger receptor expression and response to oxidative stress is linked to defective bacterial phagocytosis in COPD macrophages
  • MAPKAP kinase 2(MK2) expression is associated with severe asthma
Show more 3.2 Airway Cell Biology and Immunopathology

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society